Pharmaceutical News Wrap Up: December 2014

The pharmaceutical attorneys at Simmons Hanly Conroy understand the importance of staying up to date on the latest headlines. Below is a list of some of the most recent pharmaceutical news concerning U.S. Food and Drug Administration (FDA) recalls, approvals and warning label changes, medical studies and other pharmaceutical news taking place throughout the world.

  • FDA: Some batches of Hepa-A vaccine recalled
    The FDA has issued a voluntary recall of some lots of Hepatitis A vaccines under the brand name Epaxal with registration number BR-426. The recall was issued because of a quality issue, including traces of iron oxide particles being released from the stopper feeding station on the filling lines at the manufacturing facility.
  • Boston Scientific ordered to pay $26.7 million over mesh devices
    Boston Scientific Corp, a manufacturer and marketer of transvaginal mesh (TVM) devices, has been ordered to pay a total of $26.7 million to four women as a result of selling faulty TVM devices. The company is facing 14,000 federal lawsuits over its mesh devices.
  • FDA label changes to simplify medication safety during pregnancy
    The U.S. Food and Drug Administration (FDA) has announced a new system for labeling medications for safe use during pregnancy, lactation and reproduction. This new system should help assure more women about which medications are safe to take during and after pregnancy, especially women who have medical conditions or health problems that develop during pregnancy.
Simmons Support Team
Simmons Hanly ConroyWritten by:

Editorial Team

The Simmons Hanly Conroy Editorial Team consists of journalists, writers and editors who strive to deliver accurate and useful information to families needing legal help. Our team works alongside the firm's attorneys and partners, as well as with medical professionals and other specialists, to keep all information relevant and helpful.